# ZIVOW (Zivo Bioscience, Inc.) - SEC EDGAR Financial Statements

> Zivo Bioscience, Inc. reported $209K in revenue and a net loss of $8.49M for the trailing twelve months ended September 30, 2025 (up 108.3% year over year), with a 31.7% gross margin and a -4045.7% operating margin.

- Canonical: https://convexityos.com/fundamentals/ZIVOW
- Markdown: https://convexityos.com/fundamentals/ZIVOW.md
- SEC CIK: 0001101026
- Reporting currency: USD
- Latest filing period: September 30, 2025
- Last synced: Nov 21, 2026, 05:03 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001101026&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $209K | +108.3% YoY |
| Operating Income | TTM | -$8.46M | -4045.7% margin |
| Net Income | TTM | -$8.49M | -4059.7% net margin |
| Diluted EPS | TTM | -$2.22 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2025 | -- | Total debt: $286K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $157K | $28K | $0 | $0 | $20K | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $108K | $16K | $0 | -- | -- | -- | -- | -- | -- | -- |
| **Gross Profit** | $49K | $12K | $0 | -- | -- | -- | -- | -- | -- | -- |
| Research & Development | $3.13M | $1.38M | $2.24M | $1.95M | $3.75M | $2.31M | $2.81M | $2.38M | $789K | $1.03M |
| Total Operating Expenses | $13.41M | $7.27M | $8.73M | $8.65M | $8.58M | $8.35M | $6.13M | $6.33M | $3.49M | -- |
| **Operating Income** | -$13.36M | -$7.26M | -$8.73M | -$8.65M | -$8.56M | -$8.35M | -$6.13M | -$6.33M | -$3.49M | -$3.06M |
| **EBITDA** | -- | -- | -- | -$8.65M | -$8.56M | -$8.35M | -$6.13M | -$6.31M | -$3.47M | -$3.03M |
| Interest Expense | -- | $24K | $13K | $45K | $98K | -- | -- | -- | -$35K | -$2.4K |
| **Net Income** | -$13.38M | -$7.78M | -$8.75M | -$8.76M | -$9.11M | -$11.51M | -$14.64M | -$10.04M | -$6.06M | -$5.79M |
| Basic EPS | -- | -- | -- | -- | -$0.02 | -$0.04 | -$0.09 | -$0.07 | -$0.05 | -$0.04 |
| **Diluted EPS** | -$4.23 | -$4.60 | -- | -- | -$0.02 | -$0.04 | -$0.09 | -$0.07 | -$0.05 | -$0.04 |
| Basic Shares Outstanding | -- | -- | -- | -- | 406.2M | 276.4M | 156.7M | 139.2M | 133.8M | 130.9M |
| Diluted Shares Outstanding | 3.2M | 1.7M | -- | -- | 406.2M | 276.4M | 156.7M | 139.2M | 133.8M | 130.9M |

### Income Statement (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $66K | $53K | $0 | $90K | $32K | $0 | $36K | $12K |
| Cost of Revenue | $44K | $35K | $0 | $63K | $22K | $0 | $23K | $7.7K |
| **Gross Profit** | $21K | $18K | $0 | $27K | $9.4K | $0 | $13K | $4.1K |
| Research & Development | $203K | $480K | $2.77M | $243K | $326K | $2.25M | $313K | $312K |
| Total Operating Expenses | $1.04M | $1.65M | $4.21M | $1.62M | $2.27M | $8.23M | $1.29M | $1.90M |
| **Operating Income** | -$1.02M | -$1.63M | -$4.21M | -$1.60M | -$2.26M | -$8.23M | -$1.28M | -$1.90M |
| Interest Expense | $13K | $7.4K | $2.4K | -- | $8.6K | $6.8K | $2.6K | -$44K |
| Income Tax Expense | -- | -- | -- | -- | $0 | $0 | $0 | -- |
| **Net Income** | -$1.03M | -$1.64M | -$4.21M | -$1.60M | -$2.27M | -$8.24M | -$1.28M | -$1.91M |
| **Diluted EPS** | -$0.27 | -$0.43 | -$1.12 | -- | -$0.67 | -$2.78 | -$0.47 | -- |
| Diluted Shares Outstanding | 3.8M | 3.8M | 3.8M | -- | 3.4M | 3.0M | 2.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | $1.80M | $8.90M | $138K | $346K | $389K | $317K | $507K | $17K |
| **Cash & Short-Term Investments** | -- | -- | $1.80M | $8.90M | $138K | $346K | $389K | $317K | $507K | $17K |
| Accounts Receivable, Net | $2.2K | $3.7K | $0 | -- | -- | $0 | -- | -- | -- | -- |
| **Total Current Assets** | $1.64M | $425K | $1.90M | $8.96M | $168K | $369K | $412K | $332K | $520K | $29K |
| Property, Plant & Equipment, Net | -- | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $19K | $44K |
| **Total Non-Current Assets** | $7.7K | $130K | $221K | $30K | $52K | $0 | $0 | $0 | $198K | $44K |
| **Total Assets** | $1.64M | $556K | $2.12M | $8.99M | $220K | $369K | $412K | $332K | $737K | $73K |
| Accounts Payable | $547K | $993K | $491K | $654K | $1.56M | $1.37M | $422K | $542K | $666K | $1.11M |
| **Total Current Liabilities** | $2.04M | $2.76M | $2.03M | $2.95M | $11.39M | $8.71M | $22.69M | $4.56M | $11.18M | $4.97M |
| **Total Non-Current Liabilities** | $116K | $0 | $106K | $0 | $137K | $0 | $0 | $12.08M | $3.18M | $4.60M |
| **Total Liabilities** | $2.16M | $2.76M | $2.13M | $2.95M | $11.53M | $8.71M | $22.69M | $16.64M | $14.36M | $9.57M |
| **Total Debt (incl. Leases)** | -- | $106K | $205K | $15K | $60K | -- | -- | -- | -- | -- |
| Common Stock | $3.6K | $2.4K | $1.6K | $9.4K | $5.2K | $397K | $180K | $141K | $137K | $132K |
| Retained Earnings | -$137.0M | -$123.6M | -$115.8M | -$107.1M | -$99.06M | -$89.96M | -$78.45M | -$63.81M | -$53.77M | -$47.71M |
| **Total Stockholders' Equity** | -$515K | -$2.21M | -$11K | $6.04M | -$11.31M | -$8.34M | -$22.28M | -$16.30M | -$13.62M | -$9.50M |
| Total Equity | -$515K | -$2.21M | -$11K | $6.04M | -$11.31M | -$8.34M | -$22.28M | -$16.30M | -$13.62M | -$9.50M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Accounts Receivable, Net | $0 | $34K | $0 | $2.2K | $28K | $0 | $3.7K | $3.7K |
| **Total Current Assets** | $281K | $410K | $1.02M | $1.64M | $437K | $495K | $711K | $425K |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Non-Current Assets** | $278K | $293K | $308K | $7.7K | $59K | $80K | $106K | $130K |
| **Total Assets** | $559K | $703K | $1.33M | $1.64M | $496K | $576K | $816K | $556K |
| Accounts Payable | $993K | $861K | $655K | $547K | $788K | $1.09M | $706K | $993K |
| **Total Current Liabilities** | $3.61M | $2.96M | $2.61M | $2.04M | $2.58M | $2.87M | $3.09M | $2.76M |
| **Total Non-Current Liabilities** | $232K | $284K | $336K | $116K | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $3.85M | $3.24M | $2.95M | $2.16M | $2.58M | $2.87M | $3.09M | $2.76M |
| **Total Debt (incl. Leases)** | $286K | $301K | $315K | -- | $22K | $51K | $79K | $106K |
| Common Stock | $3.8K | $3.8K | $3.8K | $3.6K | $3.5K | $3.3K | $2.8K | $2.4K |
| Retained Earnings | -$143.9M | -$142.8M | -$141.2M | -$137.0M | -$135.4M | -$133.1M | -$124.9M | -$123.6M |
| **Total Stockholders' Equity** | -$3.29M | -$2.54M | -$1.62M | -$515K | -$2.08M | -$2.30M | -$2.27M | -$2.21M |
| Total Equity | -$3.29M | -$2.54M | -$1.62M | -$515K | -$2.08M | -$2.30M | -$2.27M | -$2.21M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$13.38M | -$7.78M | $8.75M | -$8.76M | -$9.11M | -$11.51M | -$14.64M | -$10.04M | -$6.06M | -$5.79M |
| Depreciation & Amortization | -- | -- | -- | $0 | $0 | $0 | $0 | $19K | $25K | $25K |
| Stock-Based Compensation | $1.51M | $90K | -$298K | -$105K | $1.25M | $3.61M | $88K | $2.49M | $1.20M | -- |
| Change in Receivables | $1.5K | -$3.7K | $0 | -- | -- | -- | -- | -- | -- | -- |
| Change in Payables | -$446K | $502K | -$164K | -$905K | $187K | $950K | -$119K | -$125K | -$448K | -$21K |
| **Operating Cash Flow** | -$4.31M | -$5.80M | -$7.10M | -$6.80M | -$2.59M | -$3.71M | -$5.01M | -$4.24M | -$2.54M | -$2.30M |
| **Investing Cash Flow** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock Issued | $5.60M | $485K | $0 | $1.51M | $401K | $2.65M | $3.43M | $0 | -- | -- |
| **Financing Cash Flow** | $5.58M | $4.28M | $0 | $15.57M | $2.38M | $3.66M | $5.08M | $4.05M | $3.03M | $2.31M |
| **Net Change in Cash** | $1.27M | -$1.52M | -$7.10M | $8.76M | -$208K | -- | -- | -- | $490K | $15K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.03M | -$1.64M | -$4.21M | -$1.60M | -$2.27M | -$8.24M | -$1.28M | -$1.91M |
| Change in Receivables | -- | -- | $2.2K | $26K | -$28K | $3.7K | $0 | -- |
| Change in Payables | $132K | $206K | $108K | -$241K | -$306K | $388K | -$287K | $602K |
| **Operating Cash Flow** | -$267K | -$476K | -$1.43M | -$906K | -$1.09M | -$624K | -$1.70M | -$716K |
| **Investing Cash Flow** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock Issued | $245K | $150K | -- | $2.42M | $1.41M | $1.63M | $131K | -- |
| **Financing Cash Flow** | $314K | -$31K | $405K | $2.29M | $1.24M | $487K | $1.56M | -$495K |
| **Net Change in Cash** | $47K | -$507K | -$1.03M | $1.38M | $157K | -$136K | -$136K | -$1.21M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 31.1% | 42.0% | -- | -- | -- | -- | -- | -- | -- | -- |
| **Operating Margin** | -8498.9% | -26267.7% | -- | -- | -42778.4% | -- | -- | -- | -- | -- |
| **Net Profit Margin** | -8513.4% | -28127.2% | -- | -- | -45528.6% | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -- | -- | -- | -144.9% | -- | -- | -- | -- | -- | -- |
| Return on Assets (ROA) | -814.6% | -1399.5% | -411.9% | -97.4% | -4135.6% | -3116.0% | -3556.5% | -3021.1% | -821.9% | -7965.2% |
| Current Ratio | 0.80x | 0.15x | 0.94x | 3.04x | 0.01x | 0.04x | 0.02x | 0.07x | 0.05x | 0.01x |
| Quick Ratio | -- | -- | 0.89x | 3.02x | 0.01x | 0.04x | 0.02x | 0.07x | 0.05x | 0.00x |
| Debt to Equity | -- | -- | -- | 0.00x | -- | -- | -- | -- | -- | -- |
| **Revenue Growth (YoY)** | +468.6% | -- | -- | -100.0% | -- | -- | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | +321.6% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -- | -- | -- | -950.3% |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -500.0% |
| 5Y Net Income / Share Growth | -- | -- | -- | -- | -- | -866.6% | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 31.7% | 31.1% | 30.0% | 31.1% | 33.0% | 35.0% | 38.0% | 42.0% |
| **Operating Margin** | -4045.7% | -5544.9% | -13411.4% | -8498.9% | -17289.4% | -21871.9% | -10365.6% | -26267.7% |
| **Net Profit Margin** | -4059.7% | -5558.3% | -13430.1% | -8513.4% | -17327.3% | -22333.7% | -11176.5% | -28127.2% |
| Return on Assets (ROA) | -1516.8% | -1382.2% | -1225.7% | -814.6% | -2762.8% | -2301.7% | -867.5% | -1399.5% |
| Current Ratio | 0.08x | 0.14x | 0.39x | 0.80x | 0.17x | 0.17x | 0.23x | 0.15x |
| **Revenue Growth (YoY)** | +108.3% | -- | -100.0% | +662.7% | +166.9% | -100.0% | -- | -- |
| Gross Profit Growth (YoY) | +125.3% | -- | -100.0% | +553.6% | +128.8% | -100.0% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
